Guggenheim Capital LLC Moderna, Inc. Transaction History

Guggenheim Capital LLC

$12 Billion
Q4 2024

A detailed history of Guggenheim Capital LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 53,633 shares of MRNA stock, worth $1.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

53,633

Previous 144,688 62.93%

Holding current value

$1.8 Million

Previous $9.67 Million 76.94%

% of portfolio

0.02%

Previous 0.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$36.85 - $63.93 $3.36 Million - $5.82 Million	-91,055 Reduced 62.93%	53,633 $2.23 Million
Q3 2024 Nov 13, 2024	BUY	$63.64 - $125.14 $837,311 - $1.65 Million	13,157 Added 10.0%	144,688 $9.67 Million
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $727,497 - $1.2 Million	-7,188 Reduced 5.18%	131,531 $15.6 Million
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $1.77 Million - $2.4 Million	-20,790 Reduced 13.03%	138,719 $14.8 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $878,050 - $1.32 Million	12,632 Added 8.6%	159,509 $15.9 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $493,812 - $648,496	5,122 Added 3.61%	146,877 $15.2 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $1.74 Million - $2.35 Million	14,669 Added 11.54%	141,755 $17.2 Million
Q1 2023 May 10, 2023	BUY	$135.66 - $197.02 $821,556 - $1.19 Million	6,056 Added 5.0%	127,086 $19.5 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $161,943 - $287,334	-1,368 Reduced 1.12%	121,030 $21.7 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $1.39 Million - $2.28 Million	-11,762 Reduced 8.77%	122,398 $14.5 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $414,640 - $625,128	-3,540 Reduced 2.57%	134,160 $19.2 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $3.74 Million - $6.95 Million	-29,589 Reduced 17.69%	137,700 $23.7 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $9.32 Million - $15.2 Million	41,269 Added 32.75%	167,289 $42.5 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $920,885 - $2.01 Million	-4,150 Reduced 3.19%	126,020 $48.5 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $388,950 - $703,530	2,994 Added 2.35%	130,170 $30.6 Million
Q1 2021 May 13, 2021	SELL	$109.18 - $185.98 $2.2 Million - $3.75 Million	-20,184 Reduced 13.7%	127,176 $16.7 Million
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $1.75 Million - $4.51 Million	-26,563 Reduced 15.27%	147,360 $15.4 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $2.73 Million - $4.77 Million	50,270 Added 40.65%	173,923 $12.3 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $3.67 Million - $9.89 Million	123,653 New	123,653 $7.94 Million

Others Institutions Holding MRNA

# of Institutions

923

Shares Held

255M

Call Options Held

19M

Put Options Held

24.3M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $13.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Moderna, Inc. Transaction History